Gastric cancer is one of the malignant tumors with high mortality in China. Prediction of prognosis of the patients with advanced gastric cancer can benefit from accurate prognosis and individual treatment.
18
F-fluorodeoxyglucose (
18
F-FDG) PET/CT can provide both metabolic and morphological information
which becomes one of the most sensitive tools to stage
evaluate the efficacy of therapy and predict the outcomes of patients with malignancy. This paper reviews the predictive value of pretreatment and early
18
F-FDG PET/CT in prognosis for advanced gastric cancer.